- Home
- GTEC vs SLGL Comparison
GTEC vs SLGL Comparison
Compare GTEC & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTEC | SLGL |
|---|---|---|
| Founded | 2006 | 1997 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7M | 117.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | GTEC | SLGL |
|---|---|---|
| Price | $1.06 | $39.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $50.00 |
| AVG Volume (30 Days) | ★ 212.4K | 15.3K |
| Earning Date | 11-07-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $86,168,664.00 | $18,970,000.00 |
| Revenue This Year | $5.64 | $121.82 |
| Revenue Next Year | $3.93 | N/A |
| P/E Ratio | $1.13 | ★ N/A |
| Revenue Growth | N/A | ★ 62.04 |
| 52 Week Low | $0.92 | $4.02 |
| 52 Week High | $2.92 | $52.26 |
Technical Indicators
Market Signals| Indicator | GTEC | SLGL |
|---|---|---|
| Relative Strength Index (RSI) | 50.16 | 54.64 |
| Support Level | $0.99 | $38.30 |
| Resistance Level | $1.09 | $44.04 |
| Average True Range (ATR) | 0.07 | 3.60 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 66.00 | 60.95 |
Price Performance
Historical ComparisonAbout GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.